Профиль компании
- Фондовый код
- 068270
- ISIN-код
- KR7068270008
- Валюта
- Korean Won (KRW)
- Дата IPO
- 2005-07-19

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gast...